Clinical trials of small interfering RNA (siRNA) targeting vascular endothelial growth factor-A
(VEGFA) or its receptor VEGFR1 (also called FLT1), in patients with blinding choroidal …

Age-related macular degeneration (AMD) is the leading cause of irreversible blindness in
industrialized nations, affecting 30–50 million people worldwide. The earliest clinical …

Corneal avascularity—the absence of blood vessels in the cornea—is required for optical
clarity and optimal vision, and has led to the cornea being widely used for validating pro-and …

Purpose: To evaluate the area of the foveal avascular zone (FAZ) detected by en face OCTA
(AngioVue, Avanti OCT; Optovue) in healthy and diabetic eyes. Methods: Retrospective …

Age-related macular degeneration (AMD), a leading cause of blindness worldwide, is as
prevalent as cancer in industrialized nations. Most blindness in AMD results from invasion of …

Diabetic macular edema (DME), characterized by exudative fluid accumulation in the
macula, is the most common form of sight-threatening retinopathy in patients with diabetes …

Purpose: To study the association between the distributions of microaneurysms detected by
en face optical coherence tomography angiography (OCTA) and diabetic macular edema …

Neovascularization in response to tissue injury consists of the dual invasion of blood
(hemangiogenesis) and lymphatic (lymphangiogenesis) vessels. We reported recently that …

Background and Objectives: This study aimed to elucidate the role of laser photocoagulation
therapy in the treatment of diabetic macular edema (DME) as an alternative to, or in …

Purpose: The purpose of this study was to compare the angiographic findings of polypoidal
choroidal vasculopathy (PCV) detected by indocyanine green angiography (ICGA) and en …